IPO - AtriCure, Inc.

Form Type: S-3ASR

Filing Date: 2025-02-14

Corporate Action: Ipo

Type: New

Accession Number: 000119312525027153

Filing Summary: AtriCure, Inc. filed a registration statement on Form S-3ASR with the SEC on February 14, 2025. The company, incorporated in Delaware, aims to offer and sell various securities, which may include common stock, preferred stock, debt securities, warrants, depositary shares, purchase contracts, and units. The offering is part of a 'shelf' registration process allowing for sales in one or more offerings over time. The firm's common stock is listed on the NASDAQ under the symbol 'ATRC'. This document outlines the risks of investing in such securities and mentions that the company will provide terms for these offerings in prospectus supplements. AtriCure is a medical device company specializing in treatments for atrial fibrillation and related conditions. The proceeds from the sales may be used for general corporate purposes including debt payment, product development, and potential acquisitions. Investors are urged to read both the document and any accompanying prospectus supplements before making investment decisions.

Document Link: View Document